News

Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...
GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl ...
Patients taking a GLP-1 for diabetes have a lower risk for AF at 3 years than those on other medications, report ...
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...
FuturHealth offers both compounded semaglutide and FDA-approved name-brand options like Wegovy and Ozempic. For most users, ...
While research suggests having a higher weight may increase your risk for certain conditions, people can be healthy at every ...
Cognitive performance was not different among four classes of glucose-lowering medications for type 2 diabetes, data from the GRADE clinical trial showed.
The first is patients taking GLP-1s will eat fewer calories and the second is they will move away from “heavily processed foods” towards healthier, simpler foods with clean labels, he said.
Unless you are from another planet, you’ve heard all about the new weight loss medications taking the world by storm. These ...
Women often experience atypical cardiovascular symptoms and are at a higher risk for heart failure. Clinical studies have ...
“GLP-1 agonists represent a major breakthrough in ... “They have been linked to reducing inflammation and supporting metabolic function, and this makes them more than just weight-loss aids ...
The GLP-1 effect was transformational for Shealy Long ... ‘Am I going to be able to function today?’” SELF does not provide medical advice, diagnosis, or treatment. Any information published ...